Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma
- PMID: 28751561
- PMCID: PMC5622860
- DOI: 10.3324/haematol.2016.160192
Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma
Abstract
Splenic diffuse red pulp lymphoma is an indolent small B-cell lymphoma recognized as a provisional entity in the World Health Organization 2008 classification. Its precise relationship to other related splenic B-cell lymphomas with frequent leukemic involvement or other lymphoproliferative disorders remains undetermined. We performed whole-exome sequencing to explore the genetic landscape of ten cases of splenic diffuse red pulp lymphoma using paired tumor and normal samples. A selection of 109 somatic mutations was then evaluated in a cohort including 42 samples of splenic diffuse red pulp lymphoma and compared to those identified in 46 samples of splenic marginal zone lymphoma and eight samples of hairy-cell leukemia. Recurrent mutations or losses in BCOR (the gene encoding the BCL6 corepressor) - frameshift (n=3), nonsense (n=2), splicing site (n=1), and copy number loss (n=4) - were identified in 10/42 samples of splenic diffuse red pulp lymphoma (24%), whereas only one frameshift mutation was identified in 46 cases of splenic marginal zone lymphoma (2%). Inversely, KLF2, TNFAIP3 and MYD88, common mutations in splenic marginal zone lymphoma, were rare (one KLF2 mutant in 42 samples; 2%) or absent (TNFAIP3 and MYD88) in splenic diffuse red pulp lymphoma. These findings define an original genetic profile of splenic diffuse red pulp lymphoma and suggest that the mechanisms of pathogenesis of this lymphoma are distinct from those of splenic marginal zone lymphoma and hairy-cell leukemia.
Copyright© 2017 Ferrata Storti Foundation.
Figures



Similar articles
-
KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype.Leukemia. 2015 May;29(5):1177-85. doi: 10.1038/leu.2014.330. Epub 2014 Nov 27. Leukemia. 2015. PMID: 25428260
-
Splenic Diffuse Red Pulp Small B-Cell Lymphoma with Overlapping Clinical and Immunophenotypic Features with Hairy Cell Leukaemia: A Case Report and a Review of the Literature.Genes (Basel). 2025 Apr 19;16(4):467. doi: 10.3390/genes16040467. Genes (Basel). 2025. PMID: 40282427 Free PMC article. Review.
-
Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing.Clin Cancer Res. 2015 Sep 15;21(18):4174-4183. doi: 10.1158/1078-0432.CCR-14-2759. Epub 2015 Mar 16. Clin Cancer Res. 2015. PMID: 25779943 Free PMC article.
-
Splenic diffuse red pulp small-B cell lymphoma: toward the emergence of a new lymphoma entity.Discov Med. 2012 Apr;13(71):253-65. Discov Med. 2012. PMID: 22541613 Review.
-
Splenic diffuse red pulp lymphoma has a distinct pattern of somatic mutations amongst B-cell malignancies.Leuk Lymphoma. 2017 Mar;58(3):666-675. doi: 10.1080/10428194.2016.1196813. Epub 2016 Jun 27. Leuk Lymphoma. 2017. PMID: 27347751
Cited by
-
Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders.Front Oncol. 2022 Dec 22;12:1068981. doi: 10.3389/fonc.2022.1068981. eCollection 2022. Front Oncol. 2022. PMID: 36620555 Free PMC article. Review.
-
MAP-Kinase-Driven Hematopoietic Neoplasms: A Decade of Progress in the Molecular Age.Cold Spring Harb Perspect Med. 2021 May 3;11(5):a034892. doi: 10.1101/cshperspect.a034892. Cold Spring Harb Perspect Med. 2021. PMID: 32601132 Free PMC article. Review.
-
The Genomics of Hairy Cell Leukaemia and Splenic Diffuse Red Pulp Lymphoma.Cancers (Basel). 2022 Jan 29;14(3):697. doi: 10.3390/cancers14030697. Cancers (Basel). 2022. PMID: 35158965 Free PMC article. Review.
-
BCOR gene alterations in hematologic diseases.Blood. 2021 Dec 16;138(24):2455-2468. doi: 10.1182/blood.2021010958. Blood. 2021. PMID: 33945606 Free PMC article. Review.
-
The genomic landscape of transformed splenic diffuse red pulp small B-cell lymphoma.EJHaem. 2024 Oct 4;5(5):1014-1020. doi: 10.1002/jha2.1018. eCollection 2024 Oct. EJHaem. 2024. PMID: 39415899 Free PMC article.
References
-
- Traverse-Glehen A, Baseggio L, Bauchu EC, et al. Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity? Blood. 2008;111(4):2253–2260. - PubMed
-
- Baseggio L, Traverse-Glehen A, Callet-Bauchu E, et al. Relevance of a scoring system including CD11c expression in the identification of splenic diffuse red pulp small B-cell lymphoma (SRPL). Hematol Oncol. 2011;29(1):47–51. - PubMed
-
- Miguet L, Lennon S, Baseggio L, et al. Cell-surface expression of the TLR homolog CD180 in circulating cells from splenic and nodal marginal zone lymphomas. Leukemia. 2013;27(8):1748–1750. - PubMed
-
- Piris MA, Foucar K, Mollejo M, Campo E, Falini B. Splenic B-cell lymphoma/leukaemia unclassifiable. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Fourth Edition. IARC Press Lyon; 2008;191–193.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases